Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV004017310 | SCV000060268 | uncertain significance | not provided | 2023-02-07 | criteria provided, single submitter | clinical testing | The c.690-6G>A variant in TNNT2 has been identified in 2 individuals with dilated cardiomyopathy (DCM) who also carried a potentially disease-causing variant in TNNT2, which was confirmed in cis in one of these individuals, as well as 1 individual with hypertrophic cardiomyopathy (HCM; Morales 2010 PMID: 20973921, Ntusi 2016 PMID: 27841901, LMM data). This variant has also been reported by other clinical laboratories in ClinVar (Variation ID 43665) and has been identified in 0.00065% (1/15284) of Latino chromosomes by gnomAD (http://gnomad.broadinstitute.org, v.3.2.1). This variant is located in the 3' splice region. Computational tools do not suggest an impact to splicing. However, this information is not predictive enough to rule out pathogenicity. In summary, while the clinical significance of this variant is uncertain, these data suggest that it is more likely to be benign. ACMG/AMP Criteria applied: BP2, PM2_Supporting. |
Gene |
RCV000036613 | SCV000514926 | benign | not specified | 2015-05-08 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Illumina Laboratory Services, |
RCV001099020 | SCV001255428 | uncertain significance | Hypertrophic cardiomyopathy 2 | 2017-04-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Illumina Laboratory Services, |
RCV001099021 | SCV001255429 | uncertain significance | Dilated cardiomyopathy 1D | 2017-04-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Illumina Laboratory Services, |
RCV001099022 | SCV001255430 | uncertain significance | Cardiomyopathy, familial restrictive, 3 | 2017-04-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Color Diagnostics, |
RCV001192357 | SCV001360407 | likely benign | Cardiomyopathy | 2019-10-22 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000036613 | SCV001362089 | uncertain significance | not specified | 2019-11-19 | criteria provided, single submitter | clinical testing | Variant summary: TNNT2 c.690-6G>A alters a non-conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. 5/5 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 1.6e-05 in 251442 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.690-6G>A has been reported in the literature in individuals affected with dilated- and hypertrophic cardiomyopathy (Morales_2010, Pugh_2014). These reports however, do not provide unequivocal conclusions about association of the variant with the disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation, and both of them classified the variant as benign (1x) or likely benign (1x). Based on the evidence outlined above, the variant was classified as VUS-possibly benign. |
Invitae | RCV001426925 | SCV001629588 | likely benign | Hypertrophic cardiomyopathy 2; Dilated cardiomyopathy 1D; Cardiomyopathy, familial restrictive, 3 | 2023-09-29 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV001192357 | SCV004823267 | likely benign | Cardiomyopathy | 2024-01-03 | criteria provided, single submitter | clinical testing |